Introduction: In the era of novel anti-myeloma agents and monoclonal antibodies (daratumumab) and due to their high cost, earlier low cost regimens (VAD or CyBorD) may be used.
Published 11 Feb, 2019
This report describes a case of Acute Promyelocytic Leukemia (APL) presented differentiation syndrome with typical symptoms (edema, acute renal failure and subcutaneous hemorrhage) after treatment with All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO).
Published 14 Sep, 2018
Introduction: Mixed cellularity Hodgkin’s Lymphoma (HL) is a subtype of classic HL (c-LH), constituting the second most common subtype and 15% to 30% of all cases of HL.
Published 12 Jul, 2018
The prevention and treatment of chemotherapy-induced neutropenia (neutrophil count <0.5 × 109/L) remain a challenge for the clinician, especially in fragile patients receiving myelosuppressive drugs [1].
Published 23 Apr, 2018
Supportive care is an area of high importance in Oncology.
Published 05 Mar, 2018
The incidence of Hodgkin Lymphoma (HL) has increased among adolescents and young adults in recent decades, but the relevant risk factors in early life are still unknown.
Published 05 Mar, 2018
Leukemia is a common reason of mortality in worldwide and useful therapeutic strategy is needed in order to its incidence.
Published 08 Feb, 2017
Isolated laryngeal amyloidosis is a rare presentation of amyloid deposition.
Published 27 Dec, 2017
Renowned Editors
MIT, John Hopkins University, Stanford University, University of Michigan...300+
Rapid Peer Review
We assure 20 days rapid peer review process
Open Access
Open Access is the free, immediate, online availability of novel research
High Visibility
Published articles are easy to find on google, google scholar and other databases